Repository logo
 
Loading...
Thumbnail Image
Publication

Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn's Disease Patient

Use this identifier to reference this record.
Name:Description:Size:Format: 
Azathioprine-Induced.pdf144.08 KBAdobe PDF Download

Advisor(s)

Abstract(s)

Introduction: Azathioprine (AZA) is a widely used immunosuppressive drug in inflammatory bowel disease (IBD). The occurrence of adverse effects (AEs) is a major downside in the use of this drug, leading to treatment withdrawal in a variable proportion of patients. Case presentation: We report the case of a Crohn's disease patient who developed sialadenitis as an AE to AZA. Discussion and conclusion: To our knowledge this AE has been reported only once in the literature. Sialadenitis is a common disorder and refers to inflammation of a salivary gland. It has many causes, such as bacterial and viral infections, ductal obstruction, and drugs. There are several AEs related to this drug, categorized as dose-dependent and dose-independent. Their knowledge is essential for therapeutic management in IBD, which is already challenging, requiring an individualized approach.

Description

Keywords

Azathioprine Adverse effect Sialadenitis Crohn’s disease

Citation

Alves da Silva JI, Caetano C, Pedroto I. Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn's Disease Patient. GE Port J Gastroenterol. 2020 Aug;27(5):361-363. doi: 10.1159/000505037. Epub 2020 Jan 7. PMID: 32999909; PMCID: PMC7506223.

Research Projects

Organizational Units

Journal Issue